Apr 15 |
TD Cowen says sickle cell therapies may get higher CMS payments
|
Apr 13 |
Better Buy: Bluebird Bio Vs. Novavax
|
Apr 11 |
Is This Beaten-Down Stock a Good Acquisition Target?
|
Apr 11 |
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Apr 2 |
bluebird bio, Inc. (NASDAQ:BLUE) Q4 2023 Earnings Call Transcript
|
Mar 29 |
Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst
|
Mar 26 |
bluebird bio, Inc. (BLUE) Q4 2023 Earnings Call Transcript
|
Mar 26 |
bluebird bio falls as accounting errors force restatements
|
Mar 26 |
bluebird bio reports Q4 results
|
Mar 26 |
bluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 Guidance
|